Rallybio Corp financial data

Symbol
RLYB on Nasdaq
Location
New Haven, CT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1228% % 27%
Debt-to-equity 8.9% % -23%
Return On Assets -23% % 67%
Operating Margin -5997% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 42,243,774 shares 1.8%
Common Stock, Shares, Outstanding 41,935,841 shares 1.1%
Entity Public Float $36,700,000 USD -73%
Common Stock, Value, Issued $4,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 45,058,591 shares 1%
Weighted Average Number of Shares Outstanding, Diluted 45,058,591 shares 1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $638,000 USD -29%
Research and Development Expense $23,327,000 USD -53%
General and Administrative Expense $15,607,000 USD -24%
Operating Income (Loss) $38,260,000 USD 45%
Nonoperating Income (Expense) $25,394,000 USD 366%
Net Income (Loss) Attributable to Parent $14,170,000 USD 79%
Earnings Per Share, Basic 0 USD/shares 81%
Earnings Per Share, Diluted 0 USD/shares 81%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $32,122,000 USD 27%
Marketable Securities, Current $27,197,000 USD -45%
Cash, Cash Equivalents, and Short-term Investments $59,300,000 USD -21%
Other Assets, Current $2,667,000 USD 52%
Assets, Current $66,627,000 USD -15%
Property, Plant and Equipment, Net $26,000 USD -82%
Operating Lease, Right-of-Use Asset $198,000 USD -1.5%
Other Assets, Noncurrent $810,000 USD
Assets $67,661,000 USD -14%
Accounts Payable, Current $269,000 USD -54%
Accrued Liabilities, Current $3,736,000 USD -40%
Contract with Customer, Liability, Current $424,000 USD -61%
Liabilities, Current $4,519,000 USD -45%
Contract with Customer, Liability, Noncurrent $0 USD
Operating Lease, Liability, Noncurrent $108,000 USD
Liabilities $4,627,000 USD -43%
Accumulated Other Comprehensive Income (Loss), Net of Tax $24,000 USD -86%
Retained Earnings (Accumulated Deficit) $296,146,000 USD -5%
Stockholders' Equity Attributable to Parent $63,034,000 USD -11%
Liabilities and Equity $67,661,000 USD -14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,205,000 USD 34%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $11,081,000 USD 8%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 41,935,841 shares 1.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $876,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32,122,000 USD 27%
Deferred Tax Assets, Valuation Allowance $97,970,000 USD 25%
Deferred Tax Assets, Gross $97,970,000 USD 25%
Operating Lease, Liability $154,000 USD -61%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $14,315,000 USD 79%
Lessee, Operating Lease, Liability, to be Paid $156,000 USD -62%
Property, Plant and Equipment, Gross $769,000 USD 0%
Operating Lease, Liability, Current $90,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year One $156,000 USD -32%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,000 USD -86%
Deferred Tax Assets, Operating Loss Carryforwards $45,973,000 USD 23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Additional Paid in Capital $359,152,000 USD 1.9%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $6,503,000 USD -24%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%